X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
humans (56) 56
oncology (26) 26
male (24) 24
female (20) 20
adult (18) 18
cancer (16) 16
hematology (16) 16
middle aged (15) 15
aged (14) 14
prognosis (13) 13
immunohistochemistry (12) 12
tumors (12) 12
lymphoma (11) 11
neuroblastoma (11) 11
analysis (9) 9
pathology (8) 8
b-lymphocytes - immunology (7) 7
bone marrow (7) 7
expression (7) 7
genes (7) 7
immunology (7) 7
lymphomas (7) 7
neuroblastoma - pathology (7) 7
survival (7) 7
abridged index medicus (6) 6
aged, 80 and over (6) 6
bone marrow - pathology (6) 6
cells, cultured (6) 6
in situ hybridization, fluorescence (6) 6
lymphocyte activation (6) 6
rna (6) 6
biopsy (5) 5
chemotherapy (5) 5
classification (5) 5
gene expression (5) 5
medical research (5) 5
metastases (5) 5
monoclonal-antibodies (5) 5
mutation (5) 5
neuroblastoma - genetics (5) 5
phenotype (5) 5
research (5) 5
rituximab (5) 5
surgery (5) 5
translocation, genetic (5) 5
adolescent (4) 4
antibodies, monoclonal - immunology (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
bone-marrow (4) 4
breast neoplasms - pathology (4) 4
cell cycle (4) 4
cell line (4) 4
chromosome aberrations (4) 4
cytogenetics (4) 4
dendritic cells (4) 4
diagnosis (4) 4
flow cytometry (4) 4
follow-up studies (4) 4
gene-expression (4) 4
genetic aspects (4) 4
hemic and lymphatic diseases (4) 4
infant (4) 4
medical genetics (4) 4
medicine & public health (4) 4
minimal residual disease (4) 4
mutations (4) 4
neoplasm metastasis (4) 4
neoplasm staging (4) 4
oncology, experimental (4) 4
patients (4) 4
peripheral-blood (4) 4
primary cns lymphoma (4) 4
reproducibility of results (4) 4
sensitivity and specificity (4) 4
young adult (4) 4
antibodies (3) 3
antibodies, monoclonal (3) 3
article (3) 3
b-lymphocytes - cytology (3) 3
b-lymphocytes - pathology (3) 3
biomarkers, tumor - genetics (3) 3
breast-cancer (3) 3
cell division (3) 3
child (3) 3
child, preschool (3) 3
clinical neurology (3) 3
dna - biosynthesis (3) 3
fatal outcome (3) 3
gene amplification (3) 3
genetic research (3) 3
genetics (3) 3
hematology, oncology and palliative medicine (3) 3
hydroxylase messenger-rna (3) 3
immunocytochemistry (3) 3
immunoenzyme techniques (3) 3
immunoglobulins (3) 3
infants (3) 3
kaplan-meier estimate (3) 3
lymphocytes (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 7, pp. 663 - 671
Journal Article
Journal Article
Journal Article
Acta Dermato-Venereologica, ISSN 0001-5555, 10/2017, Volume 97, Issue 9, pp. 1081 - 1086
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2018, Volume 118, Issue 11, pp. 1502 - 1512
BACKGROUND: In neuroblastoma (NB), the most powerful prognostic marker, the MYCN amplification (MNA), occasionally shows intratumoural heterogeneity (ITH),... 
BREAST-CANCER | INTRATUMORAL HETEROGENEITY | TASK-FORCE | ONCOLOGY | RISK GROUP | COMPOSITE NEUROBLASTOMA | BONE-MARROW | AMPLIFIED NEUROBLASTOMA | COMPARATIVE GENOMIC HYBRIDIZATION | GENE COPY NUMBER | WILMS-TUMOR | Amplification | Infants | Coexistence | Neuroblastoma | Patients | Chromosome aberrations | Tumors | Metastases | Index Medicus
Journal Article
ISSN 1079-9796, 2018
Background: To compare the Nordic and the Memorial Sloan-Kettering Cancer Center (MSKCC) chemotherapy protocols for Overall Survival (OS) and Progression-Free... 
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 61, pp. 103775 - 103784
Acquired mutations were recently described in cutaneous T-cell lymphomas for the JAK1, JAK3, STAT3, and STAT5B genes of the JAK-STAT pathway. In the present... 
RNA-sequencing | Cytogenetics | Primary cutaneous CD4 positive T-cell lymphoma | ATXN2L-JAK2 fusion gene | CHRONIC EOSINOPHILIC LEUKEMIA | PROTEIN | NEOPLASMS | EFFICACY | CLASSIFICATION | cytogenetics | REARRANGEMENTS | PCM1-JAK2 FUSION | RUXOLITINIB | CELL BIOLOGY | IN-VITRO | primary cutaneous CD4 positive T-cell lymphoma | MUTATIONS
Journal Article